Supplemental Figure 9 from T-cell Priming by High-Avidity Neoantigens in Lymph Nodes Augments Adoptive Immunotherapy

2026 Open access

Read full text
Authors: Megen C Wittling, Amalia M. Rivera-Reyes, Megan M. Wyatt, Anna C. Cole, Aubrey S. Smith, Guillermo O. Rangel Rivera, James H. Carmouche, Kailey G. Diatikar, Ayana T. Ruffin, Michael B. Ware, Frances Jenkins Bennett, Connor J. Dwyer
+5 more Riley M.F. Pihl, Soundharya Kumaresan, Gregory B. Lesinski, Chrystal Mary Paulos, Hannah M. Knochelmann
DOI: 10.1158/2326-6066.31484230
Cited by: 0

Abstract

Supplemental Figure 9: Viability (A) Representative flow plots showing viability of cells in the lymph node of mice given FTY720 or no treatment. Gated on Lymphocytes/Single Cells. (B) Bar graph of viability for all samples. Mann Whitney test performed (p=0.5476).

Fields of Study & Subjects

Immunotherapy and Immune Responses T-cell and B-cell Immunology Cancer Immunotherapy and Biomarkers

Publication details

Publication date
4 March 2026
Language
EN